Literature DB >> 26869104

VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage.

Diana M Monsalve1, Ignacio Campillo-Marcos1, Marcella Salzano1, Marta Sanz-García2, Lara Cantarero1, Pedro A Lazo3.   

Abstract

NBS1 is an early component in DNA-Damage Response (DDR) that participates in the initiation of the responses aiming to repair double-strand breaks caused by different mechanisms. Early steps in DDR have to react to local alterations in chromatin that are induced by DNA damage. NBS1 participates in the early detection of DNA damage and functions as a platform for the recruitment and assembly of components that are sequentially required for the repair process. In this work we have studied whether the VRK1 chromatin kinase can affect the activation of NBS1 in response to DNA damage induced by ionizing radiation. VRK1 is forming a basal preassembled complex with NBS1 in non-damaged cells. Knockdown of VRK1 resulted in the loss of NBS1 foci induced by ionizing radiation, an effect that was also detected in cell-cycle arrested cells and in ATM (-/-) cells. The phosphorylation of NBS1 in Ser343 by VRK1 is induced by either doxorubicin or IR in ATM (-/-) cells. Phosphorylated NBS1 is also complexed with VRK1. NBS1 phosphorylation by VRK1 cooperates with ATM. This phosphorylation of NBS1 by VRK1 contributes to the stability of NBS1 in ATM (-/-) cells, and the consequence of its loss can be prevented by treatment with the MG132 proteasome inhibitor of RNF8. We conclude that VRK1 regulation of NBS1 contributes to the stability of the repair complex and permits the sequential steps in DDR.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA damage foci; DNA double strand breaks; NBN; Nibrin; Phosphorylation; Signaling

Mesh:

Substances:

Year:  2016        PMID: 26869104     DOI: 10.1016/j.bbamcr.2016.02.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer.

Authors:  Namgyu Lee; Dae-Kyum Kim; Seung Hyun Han; Hye Guk Ryu; Sung Jin Park; Kyong-Tai Kim; Kwan Yong Choi
Journal:  Mol Cells       Date:  2017-09-20       Impact factor: 5.034

Review 2.  Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?

Authors:  Ignacio Campillo-Marcos; Pedro A Lazo
Journal:  Cell Mol Life Sci       Date:  2018-04-20       Impact factor: 9.261

3.  Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target Pathways.

Authors:  Hadar Vinograd-Byk; Paul Renbaum; Ephrat Levy-Lahad
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

4.  HNRNP A1 Promotes Lung Cancer Cell Proliferation by Modulating VRK1 Translation.

Authors:  Hye Guk Ryu; Youngseob Jung; Namgyu Lee; Ji-Young Seo; Sung Wook Kim; Kyung-Ha Lee; Do-Yeon Kim; Kyong-Tai Kim
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

5.  DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells.

Authors:  Rebeca Carrión-Marchante; Valerio Frezza; Ana Salgado-Figueroa; M Isabel Pérez-Morgado; M Elena Martín; Víctor M González
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17

6.  VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis.

Authors:  David S Moura; Ignacio Campillo-Marcos; Marta Vázquez-Cedeira; Pedro A Lazo
Journal:  Cell Mol Life Sci       Date:  2018-01-16       Impact factor: 9.261

7.  VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma.

Authors:  Zhen-Chuan Liu; Kuo Cao; Zhao-Hua Xiao; Liang Qiao; Xue-Qing Wang; Bin Shang; Yang Jia; Zhou Wang
Journal:  Oncotarget       Date:  2017-08-07

8.  Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.

Authors:  Aye M Mon; A Craig MacKinnon; Paula Traktman
Journal:  PLoS One       Date:  2018-09-04       Impact factor: 3.240

9.  VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes.

Authors:  Elena Martín-Doncel; Ana M Rojas; Lara Cantarero; Pedro A Lazo
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

10.  VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells.

Authors:  Elena Navarro-Carrasco; Pedro A Lazo
Journal:  Front Cell Dev Biol       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.